• Search results for Covaxin
Image Title
Covaxin

Covaxin approved for emergency use by WHO. What does this mean for Indian students?

Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant

Published on 3rd November 2021
Flu

Covaxin gets nod from India's Central Drug Authority to give to children aged 2 to 18 years. But it's not for everyone

When DGCI will grant final approval, Covaxin will be the second vaccine for the use of kids after Zydus Cadila's three-dose DNA jab is used for children above 12 years

Published on 12th October 2021
COVID_Vaccine_PTI_121

At least 73 per cent population of Odisha has developed antibodies against COVID: ICMR survey

There was also no difference in developing antibody after taking Covaxin and Covishield vaccines, ICMR's Regional Medical Research director said.

Published on 27th September 2021

Study finds that majority of Indians experience mild or no side effects post COVID-19 vax

According to the study, 70 per cent of Indians after taking the first dose of Covishield and 64 per cent with Covaxin experienced no or mild side effects

Published on 25th August 2021
Vaccine_RGGH_EPS

COVID-19: Andhra Pradesh government to vaccinate people in 18-45 age group by first week of October 

About 9 lakh doses of Covishield and Covaxin were kept ready before commencing vaccination for the 18-45 age group

Published on 24th August 2021
covid_child

We may have COVID-19 vaccine for children by September: Director, National Institute of Virology 

The NIV director informed that apart from the Covaxin, Zyuds Cadila's vaccine trial for children is also underway

Published on 19th August 2021
COVID-19-Vaccine-6-3

Mixing Covishield and Covaxin can yield better results against COVID, says ICMR's new study

The study was conducted on individuals in Uttar Pradesh who received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks

Published on 8th August 2021
covaxin-1603676480

Covaxin will soon be manufactured in Bengaluru too, Bharat Biotech seeks expansion

In April, Bharat Biotech had announced the expansion of its manufacturing capacity across multiple facilities in Hyderabad and Bengaluru to produce 700 million doses of Covaxin annually

Published on 30th June 2021
vaccine-5873170_1920

Two-year-old gets vaccine jab in UP as part of Bharat Biotech's ongoing Covaxin trials

In May, the Drugs Controller General of India (DCGI) had granted permission to Bharat Biotech to commence phase 2-3 trials of Covaxin on children as young as two

Published on 24th June 2021
coronavirus-collateral

Recruitment for clinical trial of Covaxin in 6-12 age group to start at AIIMS from June 15

The enrolment of children volunteers aged 12-18 years at the All India Institute of Medical Sciences (AIIMS) has been completed and they have been given the first dose of Covaxin

Published on 14th June 2021
covaxin-1603676480

AIIMS Delhi starts screening children aged 6 to 12 for clinical trials of Covaxin

AIIMS Patna, Mysore Medical College and Research Institute in Karnataka have also been selected to conduct clinical trials on children

Published on 14th June 2021
covaxin-1603676480

Bharat Biotech to release results of Phase 3 trials of Covaxin in July

This comes amid a raging debate on a recent pre-print study which said that while both Covaxin and Covishield showed a good immune response, Covishield produced more antibodies than Covaxin

Published on 10th June 2021
COVID-19-Vaccine-6-3

Students travelling to study abroad worried about visa cancellation over COVID vaccine shortage

Indian students who have received Covaxin or Russia's Sputnik V vaccine are being asked to inoculate again across several international institutes as these vaccines are yet to be approved by WHO

Published on 9th June 2021
covaxin-1603676480

Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in 2 to 18 age group. Here's why

Fresh application seeks to stay the operation of the order of DCGI till disposal of the ongoing petition in the interest of justice

Published on 3rd June 2021
covaxin-1603676480

Covaxin batch initiated in March will only be ready for supply in June: Bharat Biotech

The manufacturing, testing, release and distribution of vaccines are complex and multi-factorial processes with hundreds of steps, requiring a diverse pool of human resources, the firm said

Published on 28th May 2021

Search results 1 - 15 of 142